[ACRX] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
10-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -181.90%
YoY- -106.19%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 253 570 443 2,924 941 818 2,659 -32.42%
PBT -4,425 70,666 -9,846 -6,602 -12,409 -10,539 -13,057 -16.49%
Tax 3 3 5 4 3 2 2 6.98%
NP -4,371 70,663 -9,851 -6,606 -12,412 -10,541 -13,059 -16.66%
Tax Rate - -0.00% - - - - - -
Total Cost 4,624 -70,093 10,294 9,530 13,353 11,359 15,718 -18.44%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin -1,727.67 12,397.02 -2,223.70 -225.92 -1,319.02 -1,288.63 -491.12 23.31%
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -0.40 9.60 -1.65 -1.64 -3.15 -4.07 -5.76 -35.87%
EPS Diluted -0.40 9.60 -1.65 -1.64 -3.15 -4.07 -5.76 -35.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.